Electronic healthcare records (EHR)
Brand-specific influenza vaccine effectiveness in the Nordic countries
Denmark
Finland
Sweden
EU PAS number:
EUPAS1000000481
First published:
25/02/2025
StudyFinalised
Assessing inappropriate prescribing and hospitalization risk in older adults: an analysis of administrative databases in Lombardy region
Italy
EU PAS number:
EUPAS1000000472
First published:
10/02/2025
StudyFinalised
Real-world Comparative Effectiveness of Anti-EGFRs with Doublet Chemotherapy Versus Doublet Chemotherapy with or without Bevacizumab in Firstline Among RAS/RAF Wild-type, non-dMMR/MSI High mCRC Patients with Left-sided Primary Tumors in the Flatiron Health CRC Enhanced Datamart (20240215)
United States
EU PAS number:
EUPAS1000000470
First published:
12/03/2025
StudyOngoing
A Non-interventional Real-World Study on Dose Modifications of Enfortumab Vedotin (EV) in Combination with Pembrolizumab (P) in Previously Untreated Patients with Advanced Urothelial Carcinoma in Germany
Germany
EU PAS number:
EUPAS1000000467
First published:
21/02/2025
StudyPlanned
Clinical Benefit of Bulevirtide Therapy in Adult Patients With Chronic Hepatitis Delta Compared to a Historical Control Group Receiving Standard of Care
Austria
Belgium
France
Germany
Greece
Italy
Netherlands
Romania
Spain
Sweden
United Kingdom
United States
EU PAS number:
EUPAS1000000463
First published:
27/03/2025
StudyOngoing
AN ITALIAN RETROSPECTIVE-PROSPECTIVE OBSERVATIONAL STUDY ON THE USE OF ZANUBRUTINIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (AZALEA)
Italy
EU PAS number:
EUPAS1000000437
First published:
10/03/2025
StudyOngoing
Real-world data of treatment patterns, outcomes and genomic profiling in early breast cancer in Greece (SONATA study)
Greece
EU PAS number:
EUPAS1000000428
First published:
04/01/2025
StudyOngoing
Sustainability of the Achieving Clinical Audits with Electronic Records (ACAER) Asthma and COPD Quality Improvement Program on Patient Outcomes
Australia
EU PAS number:
EUPAS1000000426
First published:
22/12/2024
StudyPlanned
An Observational Study Assessing the Long-term Risk of Non-Melanoma Skin Cancer (NMSC) Among New Users of OpzeluraTM (Ruxolitinib) Cream in a Vitiligo Patient Population: Post-Authorization Safety Study (PASS)
France
Germany
United States
EU PAS number:
EUPAS1000000413
First published:
20/01/2025
StudyPlanned
A post-authorisation safety study of ABRYSVO in immunocompromised, or renally or hepatically impaired adults aged 60 years and older in a real world setting in Europe and UK
France
Spain
United Kingdom
EU PAS number:
EUPAS1000000400
First published:
25/02/2025
StudyPlanned